Symantec Discloses Investigation, Sending Shares Plunging 35%
(Bloomberg) -- Symantec Corp. plummeted 35 percent after the No. 1 maker of cybersecurity software disclosed an internal investigation into an unspecified matter and delayed the filing of its annual report.
The inquiry creates a “meaningful amount of uncertainty,” Keybanc analyst Rob Owens said in a note to clients. He has a sector-weight rating on the shares, which tumbled Friday by the most since June 2001 to as low as $18.85.
The board's audit committee is investigating “concerns raised by a former employee,” and the company's financial results and guidance could change as a result. Symantec said it had alerted the U.S. Securities and Exchange Commission.
The company also gave a disappointing earnings forecast. Fiscal first-quarter profit will be 31 cents to 35 cents per share, compared with an estimate of 41 cents, according to data compiled by Bloomberg. Revenue will be $1.14 billion to $1.17 billion, Mountain View, California-based Symantec said Thursday in a statement. Analysts projected $1.19 billion.
While Gartner Inc. predicts worldwide cybersecurity spending will rise 8 percent to $97 billion this year, Symantec is struggling with a decreasing number of people buying antivirus software for PCs, which historically has been a strong market. The company has sought to offset those declines with deals such as the $4.65 billion acquisition of Blue Coat Systems, which has lifted demand from corporations, and targeting affluent consumers concerned about identity theft with the $2.3 billion acquisition of LifeLock.
Adjusted earnings were 46 cents per share in the fiscal fourth quarter, topping the analyst average estimate of 39 cents. Revenue rose 9.6 percent to $1.22 billion, ahead of the estimate of $1.19 billion.
To contact the reporter on this story: Jordan Robertson in Washington at jrobertson40@bloomberg.net.
To contact the editors responsible for this story: Tom Giles at tgiles5@bloomberg.net, Andrew Pollack, Jillian Ward
©2018 Bloomberg L.P.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
